Nuclear Export of mRNA

Nuclear pore complexes (NPCs) are large protein complexes embedded in the nuclear membrane that act as selective channels between the nucleus and cytoplasm. Composed of proteins called nucleoporins, NPCs have a hollow cylindrical structure that allows mature mRNA to pass through when bound to nuclear transport receptors, forming an RNA-receptor complex that shuttles into the cytoplasm.

Mature mRNA associates with specific proteins including cap binding complex, exon junction complex, polyA binding proteins, hnRNPs, and SR proteins during transcription and post-transcriptional processing. Junk RNAs like pre-spliced mRNA and excised introns cannot bind these proteins and remain stalled, allowing the cell to identify correctly processed mRNA for export while degrading defective transcripts.

The nuclear RNA exosome complex is a barrel-shaped RNA-protein complex that degrades junk RNAs detected during mRNA surveillance. It threads RNA molecules through its core to reach an exonuclease enzyme that degrades the RNA into nucleotides, which are recycled back into the cellular pool for reuse in new RNA synthesis.

Nonsense-mediated decay (NMD) is a surveillance pathway that rapidly degrades mRNAs containing premature stop codons caused by sequence mutations. Since approximately 30% of inherited genetic disorders result from these mutations, NMD prevents defective mRNAs from being exported and translated into non-functional proteins, protecting cellular function.

RNA polymerase II transcripts receive a 5' methylated G cap and most gain a 3' poly A tail during post-transcriptional modification. mRNAs lacking either or both modifications are targeted for 5'→3' exonucleolytic decay before export. These modifications mark mRNA as properly processed and eligible for nuclear export to the cytoplasm.

Chemical modifications caused by reactive oxygen species, UV light, and alkylating agents can introduce single nucleotide mutations in mRNA. These oxidative damages are detected by specialized decay pathways including NMD, non-stop decay, and no-go decay, which recognize oxidized bases and direct modified mRNAs to nuclease-mediated degradation pathways.

mRNA turnover involves regulated degradation of normal cellular mRNAs when they are no longer needed for translation. This process maintains optimum mRNA levels in the cellular pool and allows cells to control protein synthesis by adjusting mRNA availability, complementing the surveillance mechanisms that eliminate defective transcripts.